Oregon Statutes 431A.890 – Prescription Monitoring Program Advisory Commission; purposes; members
(1) The Prescription Monitoring Program Advisory Commission is created for the purposes of:
Terms Used In Oregon Statutes 431A.890
- Person: includes individuals, corporations, associations, firms, partnerships, limited liability companies and joint stock companies. See Oregon Statutes 174.100
(a) Studying issues related to the prescription monitoring program established under ORS § 431A.855;
(b) Reviewing the program’s annual report and making recommendations to the Oregon Health Authority regarding the operation of the program; and
(c) Developing criteria used to evaluate program data.
(2) The commission shall consist of 11 members appointed by the authority as follows:
(a) A person nominated by the Pain Management Commission;
(b) A person who dispenses controlled substances nominated by an association representing pharmacists;
(c) A practicing dentist nominated by an association representing dentists;
(d) A practicing doctor of medicine nominated by an association representing doctors of medicine;
(e) A practicing doctor of osteopathic medicine nominated by an association representing osteopathic physicians and surgeons;
(f) A nurse authorized to prescribe controlled substances nominated by an association representing nurses;
(g) A practicing naturopathic physician nominated by an association representing naturopathic physicians;
(h) A practicing optometrist, nominated by an association representing optometrists;
(i) A representative of the authority with expertise in administering addiction services; and
(j) Two members of the public, one of whom must be an expert in information technology. [Formerly 431.976; 2017 c.409 § 13]
The amendments to 431A.890 by section 7, chapter 438, Oregon Laws 2023, become operative January 1, 2025. See section 10, chapter 438, Oregon Laws 2023. The text that is operative on and after January 1, 2025, is set forth for the user’s convenience.
(1) The Prescription Monitoring Program Advisory Commission is created for the purposes of:
(a) Studying issues related to the prescription monitoring program established under ORS § 431A.855;
(b) Reviewing the program’s annual report and making recommendations to the Oregon Health Authority regarding the operation of the program; and
(c) Developing criteria used to evaluate program data.
(2) The commission shall consist of 12 members appointed by the authority as follows:
(a) A person nominated by the Pain Management Commission;
(b) A person who dispenses controlled substances nominated by an association representing pharmacists;
(c) A practicing dentist nominated by an association representing dentists;
(d) A practicing doctor of medicine nominated by an association representing doctors of medicine;
(e) A practicing doctor of osteopathic medicine nominated by an association representing osteopathic physicians and surgeons;
(f) A nurse authorized to prescribe controlled substances nominated by an association representing nurses;
(g) A practicing naturopathic physician nominated by an association representing naturopathic physicians;
(h) A practicing optometrist, nominated by an association representing optometrists;
(i) A representative of the authority with expertise in administering addiction services; and
(j) Three members of the public, one of whom must be an expert in information technology.